DJIA 17,106.70 29.83 0.17%
NASDAQ 4,570.64 13.29 0.29%
S&P 500 2,000.02 2.10 0.11%
market minute promo

12.95 0.11 (0.86%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VNDA $12.95 0.86%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.83
Previous Close $12.84
Daily Range $12.63 - $13.02
52-Week Range $5.70 - $19.25
Market Cap $438.7M
P/E Ratio -7.09
Dividend (Yield) $0.00 (0.0%)
Volume 353,849
Average Daily Volume 597,492
Current FY EPS -$2.00





Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website:

News & Commentary Rss Feed

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

The Wildest Biotech Stock Out There

Vanda Pharmaceuticals (VNDA) Q2 2014 Results - Earnings Call Webcast

3 Small-Cap Biotechs That Institutions Are Loving

Biotech Stock Mailbag: Vanda, Navidea, Provectus

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

3 Stocks That Soared Stupendously This Week

A monster week on Wall Street? Definitely -- but these health-care stocks truly sizzled.

Here's What Billionaire John Paulson Has Bought

Might you want to buy into any of these stocks, too?

Vanda Up on EU News - Analyst Blog

Vanda Shares Jumped 29% Amid Continued Success Of Hetlioz

See More VNDA News...

VNDA's Top Competitors

VNDA $12.95 (0.86%)
Current stock: VNDA
AMGN $137.27 (1.84%)
Current stock: AMGN
GILD $106.27 (-1.10%)
Current stock: GILD
BIIB $342.99 (0.08%)
Current stock: BIIB